Excellent Numbers...AND Strong Guidance"We are pleased with the continued growth driven by strong sales of heparinase-based products” said Paul Baehr, IBEX President & CEO. “and with the continued strengthening of the Company’s balance sheet. We foresee the trend to continue for the balance of the fiscal year.”
Anybody who has followed Ibex, know that Paul would not be that positive looking forward, unless there was a high degree of certainty.
imo,
G